• New combination treatment could benefit T-ALL patients who do not respond to chemotherapy

    2 days ago - By News Medical

    T-cell acute lymphoblastic leukemia is an aggressive cancer type that mostly affects children. The standard treatment is chemotherapy, but about one in four patients do not respond or develop resistance to this.
    Read more ...

     

  • New drug class effective in treating certain types of ovarian cancers

    2 days ago - By News Medical

    A study published today in Nature Communications shows that the drug rucaparib has been effective in treating certain types of ovarian cancers if used early in treatment, after a diagnosis, and before the cancer cells build up a resistance to chemotherapy.
    Read more ...